BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26060153)

  • 21. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A
    Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma].
    Chang BD; Cao LS; Zhou HL
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):687-90. PubMed ID: 20021866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype.
    Steurer S; Seddiqi AS; Singer JM; Bahar AS; Eichelberg C; Rink M; Dahlem R; Huland H; Sauter G; Simon R; Minner S; Burandt E; Stahl PR; Schlomm T; Wurlitzer M; Schlüter H
    Anticancer Res; 2014 May; 34(5):2255-61. PubMed ID: 24778028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN expression in renal cell carcinoma and oncocytoma and prognosis.
    Hager M; Haufe H; Kemmerling R; Mikuz G; Kolbitsch C; Moser PL
    Pathology; 2007 Oct; 39(5):482-5. PubMed ID: 17886097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation.
    Ku JH; Park YH; Myung JK; Moon KC; Kwak C; Kim HH
    Urol Oncol; 2011; 29(6):731-7. PubMed ID: 19914104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
    Fritzsche FR; Oelrich B; Johannsen M; Kristiansen I; Moch H; Jung K; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(21):7035-42. PubMed ID: 18981000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma.
    Tawfik OW; Kramer B; Shideler B; Danley M; Kimler BF; Holzbeierlein J
    Arch Pathol Lab Med; 2007 Feb; 131(2):261-7. PubMed ID: 17284111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of microvascular invasion in predicting survival in renal cell carcinoma.
    Santiago-Agredano B; Álvarez-Kindelán J; Font-Ugalde P; Blanca-Pedregosa A; López-Beltrán A; Requena-Tapia MJ
    Actas Urol Esp; 2013 Sep; 37(8):504-12. PubMed ID: 23623182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma.
    Matusan K; Dordevic G; Stipic D; Mozetic V; Lucin K
    J Surg Oncol; 2006 Sep; 94(4):325-31. PubMed ID: 16917865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The expression and clinical significance of Annexin II in clear-cell renal cell carcinoma].
    Yang J; Cheng TT; Wang LN; Chen W; Li X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):59-62. PubMed ID: 22230505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical Expression of Emerin in Renal Cell Carcinomas: Does It Contribute to Histopathological Features and WHO/ISUP Grading in Predicting Prognosis?
    Argon A; Dal G; Salman T
    J Environ Pathol Toxicol Oncol; 2021; 40(2):89-98. PubMed ID: 33822520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma.
    Papworth K; Bergh A; Grankvist K; Ljungberg B; Sandlund J; Rasmuson T
    Acta Oncol; 2013 Jan; 52(1):159-65. PubMed ID: 22731830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for renal cell carcinoma: Trakya University experience from Turkey.
    Yurut-Caloglu V; Caloglu M; Kaplan M; Oz-Puyan F; Karagol H; Ibis K; Cosar-Alas R; Kocak Z; Inci O
    Eur J Cancer Care (Engl); 2010 Sep; 19(5):656-63. PubMed ID: 19832896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
    Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of caveolin-1 in renal neoplasms.
    Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
    Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.
    May M; Ficarra V; Shariat SF; Zigeuner R; Chromecki T; Cindolo L; Burger M; Gunia S; Feciche B; Wenzl V; Aziz A; Chun F; Becker A; Pahernik S; Simeone C; Longo N; Zucchi A; Antonelli A; Mirone V; Stief C; Novara G; Brookman-May S; ;
    J Urol; 2013 Aug; 190(2):458-63. PubMed ID: 23434943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
    Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
    Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
    Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
    Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
    Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.